| Mrs Agustina Fougere, MA | |
|
300 Flatbush Ave, Brooklyn Center For Psychotherapy, Brooklyn, NY 11217-2812 | |
| (718) 622-2000 | |
| Not Available |
| Full Name | Mrs Agustina Fougere |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 300 Flatbush Ave, Brooklyn, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003013772 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Agustina Fougere, MA 604 Manhattan Ave Apt 3l, Brooklyn, NY 11222-3930 Ph: (718) 349-3155 | Mrs Agustina Fougere, MA 300 Flatbush Ave, Brooklyn Center For Psychotherapy, Brooklyn, NY 11217-2812 Ph: (718) 622-2000 |
News Archive
However, in other research, white blood cells' exact roles and subtypes in severe COVID-19 are still unclear. The team writes, "It is unknown if blood cell counts before infection are associated with the risk of developing severe COVID-19." They explained that the numbers of these cell types could be influenced by several factors such as age, gender, disease status, and medications.
A new large scale study has focussed on faulty BRCA genes and their linkage to breast and ovarian cancer. The research could help doctors counsel and advise their patients in a more definitive way in terms of treatment as well as lifestyle changes that could minimize cancer risk.
A new method for creating nanofibers made of proteins, developed by researchers at Polytechnic Institute of New York University (NYU-Poly), promises to greatly improve drug delivery methods for the treatment of cancers, heart disorders and Alzheimer's disease, as well as aid in the regeneration of human tissue, bone and cartilage.
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that it has initiated a Phase 1/2 clinical study of its novel heat shock protein 90 (Hsp90) inhibitor, STA-9090 in hematologic malignancies with a once-a-week dosing schedule.
In the developing world, anemia - a blood condition exacerbated by malnutrition or parasitic disease - is a staggeringly common health problem that often goes undiagnosed.
› Verified 8 days ago
Ms. Valeria Villaran, M.A. Counselor Medicare: Not Enrolled in Medicare Practice Location: 300 Flatbush Ave, Brooklyn, NY 11217 Phone: 718-622-2000 Fax: 718-398-3328 | |
Chava Rabinowitz, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2925a Kings Hwy, Brooklyn, NY 11229 Phone: 718-382-0045 Fax: 718-859-7157 | |
Mr. Robert Stanley Burch, CASAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 567 E 105th St, Canarsie Multi Service Center, Brooklyn, NY 11236 Phone: 718-307-3018 | |
Ms. Danielle Krizni, CASAC Counselor Medicare: Not Enrolled in Medicare Practice Location: 567 E 105th St, Brooklyn, NY 11236 Phone: 718-307-3000 Fax: 718-307-3020 | |
Camille Armando, Counselor Medicare: Not Enrolled in Medicare Practice Location: 175 Remsen St, Brooklyn, NY 11201 Phone: 718-342-6700 | |
Grimaldi Martinez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2020 Coney Island Ave, Brooklyn, NY 11223 Phone: 718-676-4211 |